New strategy for treating advanced ovarian cancer shows promise in mice

On March 28, 2016 an experimental strategy for treating advanced ovarian cancer has caused tumor regression in animal models, according to a new study. The strategy uses a protein fragment, or peptide, to stimulate normal cells in the tissues surrounding cancer cells—the tumor microenvironment—to block the growth of the cancer cells. Read more here.